Recombinant human serum albumin (OsrHSA) has emerged as a significant innovation in the sector of biopharmaceuticals, offering promising breakthroughs across different health-related and industrial programs. With its structural similarity to In a natural way derived human serum albumin, OsrHSA provides a safer, additional trusted choice for therape